Episode Details
Back to Episodes
Mounjaro Gets New Heart Health Approval | Health and Fitness News
Description
FDA just approved Mounjaro for a major new use: slashing heart attack and stroke risk in high-risk type 2 diabetes patients. This breakthrough builds on its existing role in blood sugar control, with clinical trials showing an 8% drop in cardiovascular events compared to Trulicity. As more GLP-1 drugs like Ozempic gain similar approvals, the big question remains: will insurers finally cover these pricey meds? For millions battling diabetes and heart disease, this could be a game-changer.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/7b3dc31fd8e33604